PFE logo

Pfizer (PFE) Accounts payable

annual accounts payable:

$5.63B-$1.08B(-16.05%)
December 31, 2024

Summary

  • As of today (May 29, 2025), PFE annual accounts payable is $5.63 billion, with the most recent change of -$1.08 billion (-16.05%) on December 31, 2024.
  • During the last 3 years, PFE annual accounts payable has risen by +$55.00 million (+0.99%).
  • PFE annual accounts payable is now -17.27% below its all-time high of $6.81 billion, reached on December 31, 2022.

Performance

PFE Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEbalance sheet metrics

quarterly accounts payable:

$5.24B-$393.00M(-6.98%)
March 29, 2025

Summary

  • As of today (May 29, 2025), PFE quarterly accounts payable is $5.24 billion, with the most recent change of -$393.00 million (-6.98%) on March 29, 2025.
  • Over the past year, PFE quarterly accounts payable has dropped by -$351.00 million (-6.28%).
  • PFE quarterly accounts payable is now -23.04% below its all-time high of $6.81 billion, reached on December 31, 2022.

Performance

PFE quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

PFE Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-16.1%-6.3%
3 y3 years+1.0%-4.8%
5 y5 years+44.9%+31.9%

PFE Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-17.3%+1.0%-23.0%+2.6%
5 y5-year-17.3%+44.9%-23.0%+35.3%
alltimeall time-17.3%+1303.3%-23.0%+1312.8%

PFE Accounts payable History

DateAnnualQuarterly
Mar 2025
-
$5.24B(-7.0%)
Dec 2024
$5.63B(-16.1%)
$5.63B(+6.0%)
Sep 2024
-
$5.31B(+4.1%)
Jun 2024
-
$5.11B(-8.7%)
Mar 2024
-
$5.59B(-16.7%)
Dec 2023
$6.71B(-1.5%)
$6.71B(+25.7%)
Sep 2023
-
$5.34B(-12.2%)
Jun 2023
-
$6.08B(-0.7%)
Mar 2023
-
$6.12B(-10.1%)
Dec 2022
$6.81B(+22.1%)
$6.81B(+8.6%)
Sep 2022
-
$6.27B(+1.0%)
Jun 2022
-
$6.21B(+12.7%)
Mar 2022
-
$5.51B(-1.3%)
Dec 2021
$5.58B(+30.2%)
$5.58B(+18.7%)
Sep 2021
-
$4.70B(+8.6%)
Jun 2021
-
$4.33B(+6.5%)
Mar 2021
-
$4.06B(-5.1%)
Dec 2020
$4.28B(+10.2%)
$4.28B(+3.4%)
Sep 2020
-
$4.14B(+6.9%)
Jun 2020
-
$3.87B(-2.5%)
Mar 2020
-
$3.97B(+2.2%)
Dec 2019
$3.89B(-16.8%)
$3.89B(-1.4%)
Sep 2019
-
$3.94B(-1.5%)
Jun 2019
-
$4.00B(-3.7%)
Mar 2019
-
$4.16B(-11.1%)
Dec 2018
$4.67B(+0.4%)
$4.67B(+8.8%)
Sep 2018
-
$4.30B(+2.4%)
Jun 2018
-
$4.20B(+8.2%)
Mar 2018
-
$3.88B(-16.7%)
Dec 2017
$4.66B(+2.6%)
$4.66B(+33.8%)
Sep 2017
-
$3.48B(+1.2%)
Jun 2017
-
$3.44B(+1.4%)
Mar 2017
-
$3.39B(-25.2%)
Dec 2016
$4.54B(+25.3%)
$4.54B(+30.5%)
Sep 2016
-
$3.48B(+6.6%)
Jun 2016
-
$3.26B(+4.4%)
Mar 2016
-
$3.13B(-13.7%)
Dec 2015
$3.62B(+12.8%)
$3.62B(+9.9%)
Sep 2015
-
$3.29B(+12.4%)
Jun 2015
-
$2.93B(+7.6%)
Mar 2015
-
$2.72B(-15.1%)
Dec 2014
$3.21B(-0.7%)
$3.21B(+8.0%)
Sep 2014
-
$2.97B(-0.6%)
Jun 2014
-
$2.99B(+17.4%)
Mar 2014
-
$2.55B(-21.3%)
Dec 2013
$3.23B(+10.7%)
$3.23B(+41.4%)
Sep 2013
-
$2.29B(+15.6%)
Jun 2013
-
$1.98B(-39.7%)
Mar 2013
-
$3.28B(+12.3%)
Dec 2012
$2.92B(-20.6%)
$2.92B(-1.6%)
Sep 2012
-
$2.97B(-6.3%)
Jun 2012
-
$3.17B(+2.4%)
Mar 2012
-
$3.09B(-16.0%)
Dec 2011
$3.68B(-8.6%)
$3.68B(-2.3%)
Sep 2011
-
$3.77B(+1.8%)
Jun 2011
-
$3.70B(-1.4%)
Mar 2011
-
$3.75B(-6.9%)
Dec 2010
$4.03B(-7.9%)
$4.03B(+25.6%)
Sep 2010
-
$3.21B(+4.2%)
Jun 2010
-
$3.08B(+1.7%)
Mar 2010
-
$3.03B(-30.7%)
Dec 2009
$4.37B(+149.6%)
$4.37B(+76.1%)
Sep 2009
-
$2.48B(-4.4%)
Jun 2009
-
$2.60B(+65.0%)
Mar 2009
-
$1.57B(-10.2%)
Dec 2008
$1.75B(-22.9%)
$1.75B(+6.2%)
Sep 2008
-
$1.65B(-14.5%)
Jun 2008
-
$1.93B(+1.0%)
Mar 2008
-
$1.91B(-15.9%)
Dec 2007
$2.27B
$2.27B(-1.2%)
Sep 2007
-
$2.30B(+24.6%)
DateAnnualQuarterly
Jun 2007
-
$1.84B(-9.4%)
Mar 2007
-
$2.04B(+0.9%)
Dec 2006
$2.02B(-2.6%)
$2.02B(+15.9%)
Sep 2006
-
$1.74B(+0.1%)
Jun 2006
-
$1.74B(-8.0%)
Mar 2006
-
$1.89B(-8.7%)
Dec 2005
$2.07B(-22.4%)
$2.07B(+14.6%)
Sep 2005
-
$1.81B(-13.9%)
Jun 2005
-
$2.10B(-8.7%)
Mar 2005
-
$2.30B(-13.9%)
Dec 2004
$2.67B(+3.3%)
$2.67B(+14.7%)
Sep 2004
-
$2.33B(-6.1%)
Jun 2004
-
$2.48B(+0.0%)
Mar 2004
-
$2.48B(-4.2%)
Dec 2003
$2.59B(+59.7%)
$2.59B(+29.5%)
Sep 2003
-
$2.00B(-5.8%)
Jun 2003
-
$2.12B(+54.4%)
Mar 2003
-
$1.37B(-15.2%)
Dec 2002
$1.62B(+14.8%)
$1.62B(+4.4%)
Sep 2002
-
$1.55B(+1.8%)
Jun 2002
-
$1.52B(-4.2%)
Mar 2002
-
$1.59B(+12.8%)
Dec 2001
$1.41B(-17.9%)
$1.41B(-13.5%)
Sep 2001
-
$1.63B(+5.8%)
Jun 2001
-
$1.54B(+8.7%)
Mar 2001
-
$1.42B(-17.5%)
Dec 2000
$1.72B(-9.0%)
$1.72B(+21.3%)
Sep 2000
-
$1.42B(-1.6%)
Jun 2000
-
$1.44B(+68.4%)
Mar 2000
-
$855.00M(-54.7%)
Dec 1999
$1.89B(+94.5%)
$1.89B(+172.2%)
Sep 1999
-
$694.00M(-9.9%)
Jun 1999
-
$770.00M(+17.4%)
Mar 1999
-
$656.00M(-32.4%)
Dec 1998
$971.00M(+47.1%)
$971.00M(+18.8%)
Sep 1998
-
$817.00M(+0.4%)
Jun 1998
-
$814.00M(+12.4%)
Mar 1998
-
$724.00M(+9.7%)
Dec 1997
$660.00M(-27.7%)
$660.00M(-6.0%)
Sep 1997
-
$702.00M(-27.7%)
Jun 1997
-
$971.00M(+18.6%)
Mar 1997
-
$819.00M(-10.3%)
Dec 1996
$913.00M(+27.6%)
$913.00M(+21.7%)
Sep 1996
-
$750.00M(+15.0%)
Jun 1996
-
$652.00M(+8.3%)
Mar 1996
-
$602.00M(-15.8%)
Dec 1995
$715.30M(+36.3%)
$715.30M(+12.5%)
Sep 1995
-
$636.00M(-11.1%)
Jun 1995
-
$715.10M(+24.8%)
Mar 1995
-
$573.20M(+9.2%)
Dec 1994
$524.90M(+9.6%)
$524.90M(+21.3%)
Sep 1994
-
$432.90M(+1.4%)
Jun 1994
-
$427.10M(-4.9%)
Mar 1994
-
$449.00M(-6.3%)
Dec 1993
$479.10M(+5.0%)
$479.10M(+21.4%)
Sep 1993
-
$394.60M(+2.7%)
Jun 1993
-
$384.30M(+0.8%)
Mar 1993
-
$381.30M(-16.5%)
Dec 1992
$456.40M(-1.4%)
$456.40M(+4.3%)
Sep 1992
-
$437.40M(-2.0%)
Jun 1992
-
$446.10M(+1.3%)
Mar 1992
-
$440.20M(-4.9%)
Dec 1991
$462.90M(+2.8%)
$462.90M(+15.4%)
Sep 1991
-
$401.30M(-2.4%)
Jun 1991
-
$411.00M(-3.8%)
Mar 1991
-
$427.40M(-5.1%)
Dec 1990
$450.30M(+12.2%)
$450.30M(+7.7%)
Sep 1990
-
$418.00M(+10.3%)
Jun 1990
-
$379.00M(+2.2%)
Mar 1990
-
$370.90M(-7.6%)
Dec 1989
$401.40M
$401.40M

FAQ

  • What is Pfizer annual accounts payable?
  • What is the all time high annual accounts payable for Pfizer?
  • What is Pfizer annual accounts payable year-on-year change?
  • What is Pfizer quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Pfizer?
  • What is Pfizer quarterly accounts payable year-on-year change?

What is Pfizer annual accounts payable?

The current annual accounts payable of PFE is $5.63B

What is the all time high annual accounts payable for Pfizer?

Pfizer all-time high annual accounts payable is $6.81B

What is Pfizer annual accounts payable year-on-year change?

Over the past year, PFE annual accounts payable has changed by -$1.08B (-16.05%)

What is Pfizer quarterly accounts payable?

The current quarterly accounts payable of PFE is $5.24B

What is the all time high quarterly accounts payable for Pfizer?

Pfizer all-time high quarterly accounts payable is $6.81B

What is Pfizer quarterly accounts payable year-on-year change?

Over the past year, PFE quarterly accounts payable has changed by -$351.00M (-6.28%)
On this page